A venture capital term sheet is a non-binding document that outlines the key economic and governance terms of a proposed investment in a startup. It covers valuation, liquidation preferences, anti-dilution provisions, board composition, voting rights, and protective provisions. In Q2 2025, 98% of venture rounds used 1x non-participating liquidation preference, and median Series A dilution was 17.9%. [src1]
START — User needs to understand VC investment terms
├── What instrument type?
│ ├── Priced equity round → Term sheet ← YOU ARE HERE
│ ├── Convertible note → Cap + discount + interest
│ ├── SAFE → Cap + discount, no interest/maturity
│ └── Revenue-based → No equity terms
├── Which terms matter most?
│ ├── Economics → Valuation, dilution, liquidation preferences
│ ├── Control → Board seats, protective provisions
│ ├── Protection → Anti-dilution, pro-rata rights
│ └── Exit → Drag-along, registration rights
└── What stage?
├── Seed → Often SAFE/convertible instead
├── Series A → Full term sheet, first priced round
└── Series B+ → More investor-favorable terms
Founders celebrate high valuations without realizing participating preferred with 2x liquidation can reduce their payout significantly. [src1]
Build a waterfall model showing founder payout at $25M, $50M, $100M, and $500M exits under proposed terms. [src5]
Converts previous shares as if invested at the down-round price, creating devastating founder dilution. [src5]
Market standard in 95%+ of deals, creating fair adjustment blending original and down-round prices. [src1]
Investors propose a large option pool within pre-money, effectively reducing the per-share price. [src2]
Calculate equity grants needed for planned hires rather than accepting arbitrary 15-20% carve-out. [src3]
Misconception: The term sheet is a binding contract.
Reality: Non-binding except for exclusivity (30-60 days) and confidentiality. All other terms can change. [src3]
Misconception: Higher valuation always means a better deal.
Reality: $20M pre-money with clean 1x non-participating may outperform $30M pre-money with 2x participating at most exits. [src1]
Misconception: Protective provisions are optional.
Reality: Present in 90%+ of rounds. Founders can negotiate scope, not existence. [src4]
| Concept | Key Difference | When to Use |
|---|---|---|
| VC term sheet | Full priced round with detailed economics | Series A and later |
| SAFE | Simple; no valuation until priced round | Pre-seed/seed; speed matters |
| Convertible note | Debt converting to equity; maturity/interest | Bridge rounds |
| Growth equity terms | Minority stake; more negative control | Growth stage; established revenue |
Fetch this when a user asks about VC term sheet terms, liquidation preferences, anti-dilution provisions, founder dilution, option pool sizing, or negotiating a venture capital investment.